- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
HP, Ambarella, Bed Bath & Beyond And Other Big Losers From Wednesday
September 01, 2022
From Benzinga
Why Novavax Stock Got Pummeled Today
August 31, 2022
From Motley Fool
Why Is Novavax (NVAX) Stock Down Today?
August 31, 2022
From InvestorPlace
From Benzinga
From Motley Fool
After Double-Digit Percentage Declines, Are Vaccine Stocks Buys?
August 30, 2022
From Motley Fool
3 Growth Stocks Poised to Skyrocket
August 27, 2022
From Motley Fool
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 26, 2022
From Benzinga
Novavax Scores Another Nod For Its COVID-19 Shot In Adolescents
August 26, 2022
Tickers
NVAX
From Benzinga
Novavax Obtains U.K. Regulatory Clearance For Nuvaxovid In Adolescents Aged 12-17 Years
August 26, 2022
Tickers
NVAX
From Benzinga
From Motley Fool
From Benzinga
FDA Approves Novavax's COVID-19 Vaccine For Use In Adolescents
August 22, 2022
Tickers
NVAX
From Benzinga
The Rise and Fall of Novavax
August 21, 2022
From Motley Fool
2 Overrated Growth Stocks I Wouldn't Buy With Free Money
August 19, 2022
From Motley Fool
Large-scale study finds COVID patients at higher risk of brain fog and psychosis after two years compared with other respiratory illnesses
August 18, 2022
From MarketWatch
How Investors Can Outperform Warren Buffett
August 18, 2022
From Motley Fool
From Benzinga
If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
August 17, 2022
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 17, 2022
From Benzinga
From Benzinga
From Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.